Hepatitis C Therapy

Interferon/ribavirin therapy can be safe, but sustained response remains low

Published in Hepatitis Weekly, May 10th, 2004

Patients who are infected with both HIV and hepatitis C (HCV) can be safely treated for the latter infection with a combination of ribavirin (RBV) and interferon alpha-2b (IFN), according to a new study. However, adverse effects such as anemia contributed to a high dropout rate, which prevented more widespread treatment success.

Hepatitis C is often seen in combination with HIV infection, especially in intravenous drug users, or recipients of tainted blood, and co-infection leads to worse outcomes. While better treatment options have improved health and increased the lifespan of patients with HIV, their illness and mortality due to HCV remains a problem. As a result,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2004-05-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry